Burstable Cannabis Team
Cannabis In-Focus
@burstable
Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.
614 articles
Articles
Native American Tribes Emerge as Key Players in the U.S. Cannabis Industry
Over the past year, Native American tribes have become increasingly pivotal in the legal cannabis industry across the United States. Their involvement is not only reshaping the landscape of cannabis entrepreneurship but also highlighting the potential for economic growth within tribal communities. Companies such as SNDL Inc...
May 28, 2025Read more
Lophora Advances Psychedelic Therapy with Phase 1 Clinical Trial of LPH-5
Lophora, a Danish biotech company, has announced the dosing of the first subjects in its Phase 1 clinical trial for LPH-5, a novel compound aimed at treating central nervous system disorders without the hallucinogenic effects typical of traditional psychedelics. Conducted by Biotrial in Rennes, France, the trial focuses on ...
May 28, 2025Read more
HOPE Therapeutics Secures $7.8 Million in Debt Financing to Expand Mental Health Clinic Network
HOPE Therapeutics, Inc., a wholly owned subsidiary of NRx Pharmaceuticals (NASDAQ: NRXP), has taken a significant step forward in its mission to expand access to innovative mental health treatments. The company has signed a $7.8 million debt financing term sheet with Universal Capital, LLC, aimed at funding the acquisition ...
May 28, 2025Read more
Medical Cannabis Emerges as a Potential Alternative for Lupus Symptom Management
Lupus, a chronic autoimmune disease affecting more than 1.5 million individuals in Canada and the United States, presents significant challenges in symptom management and treatment. Characterized by inflammation, joint pain, fatigue, and in severe cases, organ damage, lupus has no known cure, and existing treatments may not...
May 27, 2025Read more
Cannabis Means Business Conference & Expo 2025 to Spotlight Industry Growth in New York City
The Cannabis Means Business Conference & Expo (CMB) is set to take place on June 4-5, 2025, in New York City, marking a significant event for the cannabis and psychedelic industries. This two-day B2B event, previously known as CWBExpo, has been a cornerstone for industry professionals since 2015, offering a platform for net...
May 27, 2025Read more
Perfect Union Achieves Record Growth and Expands Community Outreach in Northern California
Perfect Union, the flagship retail brand of MWG Holdings, Inc., has reported remarkable year-over-year growth across all its retail locations, with a standout performance during the 420 weekend in April 2025. The Northside Sacramento location of Perfect Union was ranked among the top 10 recreational dispensaries in the Unit...
May 27, 2025Read more
Kenny McCormick IV Launches Innovative Billboard Campaign for *LDS/LSD: The Psychedelic Hymnal*
Kenny McCormick IV, renowned for his role as Jimmy Flinders in Saturday's Warrior, has initiated a groundbreaking multi-city billboard campaign to promote his new music and storytelling venture, LDS/LSD: The Psychedelic Hymnal. This album offers a fresh take on traditional Mormon hymns, emphasizing themes of healing, creati...
May 27, 2025Read more
Nebraska Legislature Fails to Pass Medical Marijuana Bill, Impacting Economic Growth
The Nebraska Legislature's recent decision not to pass Legislative Bill 677, which sought to implement voter-approved medical marijuana laws, marks a significant setback for the cannabis industry in the state. Despite overwhelming support from voters in November, the bill failed to overcome a filibuster, with a final vote o...
May 23, 2025Read more
HOPE Therapeutics Expands Mental Health Care Footprint with Kadima Neuropsychiatry Institute Acquisition
HOPE Therapeutics, Inc., a subsidiary of NRx Pharmaceuticals (NASDAQ: NRXP), has announced the acquisition of Kadima Neuropsychiatry Institute in La Jolla, California, a move set to enhance its nationwide network of psychiatric clinics. This acquisition is not only expected to bring profitability but also to be accretive to...
May 23, 2025Read more
Delaware Legislature Considers Restricting THC-Infused Beverage Sales to Licensed Package Stores
Delaware is on the verge of implementing a significant change in the sale of THC-infused beverages, with House Bill 98 proposing to restrict their distribution to licensed package stores, removing them from bars and restaurants. Introduced by Representative Debra Heffernan, the bill has successfully passed the committee sta...
May 22, 2025Read more
Cybin CEO to Discuss Psychedelic Therapeutics and Regulatory Landscape in Upcoming Fireside Chat
Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) has announced that its CEO, Doug Drysdale, will be a featured participant in a Water Tower Research Fireside Chat scheduled for May 29, 2025, at 11 a.m. ET. This event promises to shed light on Cybin's pioneering work in the field of psychedelic-based therapeutics, with a particu...
May 22, 2025Read more
Albuquerque's Basic Income Initiative Funded by Cannabis Tax Revenue Highlights Industry's Economic Impact
Albuquerque, New Mexico, has introduced a basic income initiative designed to assist families in high-need areas, with funding partially derived from tax revenues generated by recreational marijuana sales. This program exemplifies the broader economic and social benefits that cannabis legalization can offer to communities. ...
May 21, 2025Read more
Silo Pharma Advances PTSD Treatment with Innovative Nasal Spray System
Silo Pharma (NASDAQ: SILO) has entered into a service agreement with Resyca BV to conduct a critical drug-device study on its microchip-enabled nasal spray system, a key component of its lead PTSD treatment candidate, SPC-15. This study aims to gather the necessary device data for an Investigational New Drug (IND) applicati...
May 21, 2025Read more
Green Monke Expands Its Hemp-Infused Beverage Line to New Jersey
Green Monke USA, an award-winning hemp-D9 beverage brand, has announced a strategic distribution agreement with Remarkable Liquids to launch its premium hemp beverages in New Jersey. This partnership signifies Green Monke's entry into the Northeast, expanding its reach to 10 states with a portfolio that includes 8 SKUs, suc...
May 21, 2025Read more
Pennsylvania Senate Panel Blocks Recreational Marijuana Proposal
A proposal to legalize recreational marijuana in Pennsylvania, supported by Democrats, was recently blocked by the Senate Law and Justice Committee. The bill, which aimed to allow adults to purchase cannabis from state-run stores, was defeated in a 7-3 vote, with one Democrat joining Republicans in opposition. This decision...
May 20, 2025Read more
FDA Commissioner's Endorsement Accelerates Psychedelic Therapeutics Development
Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) has highlighted the significance of recent comments by FDA Commissioner Dr. Martin Makary, which endorse the accelerated development of psychedelic therapeutics. This endorsement comes as Cybin progresses with its Phase 3 trials of CYB003 for major depressive disorder (MDD) and P...
May 20, 2025Read more
U.S. Supreme Court Ruling on CBD Case Could Reshape Cannabis Industry Standards
The U.S. Supreme Court's narrow 5-4 decision in favor of Douglas Horn, a commercial truck driver who sued three CBD companies under the federal RICO statute, underscores the growing legal complexities surrounding cannabis products. Horn alleged he was wrongfully terminated after testing positive for THC, despite using a CBD...
May 19, 2025Read more
Republican Lawmakers Advocate for Psychedelic Therapies for Veterans Amid Growing Industry Support
Rep. Morgan Luttrell (R-Texas), a retired Navy SEAL, is at the forefront of a growing number of Republican lawmakers advocating for the therapeutic use of psychedelics to treat conditions such as PTSD, depression, and suicidality among veterans. This movement, recently highlighted by The Wall Street Journal, represents a si...
May 19, 2025Read more
Silo Pharma Secures $2 Million in Public Offering to Advance Psychedelic and CNS Therapeutics
Silo Pharma, a developmental-stage biopharmaceutical company, has successfully closed a public offering raising approximately $2 million. This financial milestone is earmarked for advancing the company's pipeline of novel therapeutics, particularly in the realms of psychedelic treatments and central nervous system (CNS) dis...
May 19, 2025Read more
Florida's Recreational Cannabis Legalization Faces Legal Hurdles
The path to legalizing recreational cannabis in Florida through a constitutional amendment has encountered significant resistance due to a newly enacted state law that imposes substantial barriers on the citizen initiative process. Smart & Safe Florida, the group spearheading the marijuana amendment effort, has taken legal ...
May 16, 2025Read more
Silo Pharma Announces Public Offering to Fund Psychedelic and Cannabis Research
Silo Pharma (NASDAQ: SILO) has recently announced a public offering of approximately 3.33 million shares of common stock, along with Series A-1 and Series A-2 warrants, each priced at $0.60 per unit. This strategic move is expected to generate gross proceeds of about $2 million, before accounting for fees and expenses. The ...
May 16, 2025Read more